Yahoo
HKSE - Delayed Quote HKD

AIM Vaccine Co., Ltd. (6660.HK)

1.520 -0.040 (-2.56%)
At close: November 6 at 2:51:22 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
1,001,650 1,165,673 1,285,031 1,187,468 1,264,073
Cost of Revenue
-336,913 -405,469 -331,523 -286,452 -236,414
Gross Profit
664,737 760,204 953,508 901,016 1,027,659
Selling, General and Administrative Expenses
-735,946 -783,810 -825,396 -748,287 -943,923
Research and Development Expenses
-132,314 -191,275 -363,126 -636,401 -500,310
Other Income/Expense, Operating
26,645 22,862 24,099 32,972 35,488
Operating Income/Expenses
-841,615 -952,223 -1,164,423 -1,351,716 -1,408,745
Total Operating Profit/Loss
-176,878 -192,019 -210,915 -450,700 -381,086
Total Net Finance Income/Expense
-58,387 -54,410 -53,305 -33,125 -14,999
Net Investment Income
5,367 2,671 0 662 3,074
Irregular Income/Expenses
-513,584 -518,760 -26,488 -1,782,030 -27,215
Other Income/Expense, Non-Operating
-3,612 -4,039 -10 -5,452 -13,939
Non-Operating Income/Expenses, Total
-570,216 -574,538 -79,803 -1,819,945 -53,079
Pretax Income
-747,094 -766,557 -290,718 -2,270,645 -434,165
Provision for Income Tax
9,563 22,827 12,249 320,404 203,535
Net Income from Continuing Operations
-737,531 -743,730 -278,469 -1,950,241 -230,630
Net Income after Extraordinary Items and Discontinued Operations
-737,531 -743,730 -278,469 -1,950,241 -230,630
Non-Controlling/Minority Interests
70,365 68,270 1,235 649,236 -88,971
Net Income after Non-Controlling/Minority Interests
-667,166 -675,460 -277,234 -1,301,005 -319,601
Net Income Available to Common Stockholders
-667,166 -675,460 -277,234 -1,301,005 -319,601
Diluted Net Income Available to Common Stockholders
-667,166 -675,460 -277,234 -1,301,005 -319,601
Basic EPS
-0.54 -0.55 -0.23 -1.07 -0.27
Diluted EPS
-0.54 -0.55 -0.23 -1.07 -0.27
Basic Weighted Average Shares Outstanding
1,226,585.123 1,223,844.791 1,211,062.599 1,211,062.599 1,202,506.770
Diluted Weighted Average Shares Outstanding
1,226,585.123 1,223,844.791 1,211,062.599 1,211,062.599 1,202,506.770
Income Statement, Supplemental
EBIT
-688,707 -712,147 -237,413 -2,237,520 -419,166
EBITDA
-533,502 -553,818 -65,384 -2,062,823 -252,725
Normalized EBITDA
61,045 78,715 -4,833 -275,250 5,864
Normalized Income
-150,594.202 -130,033.200 -220,469.256 -385,070.835 -36,688.250
12/31/2022 - 10/6/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: